We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Combined MRI and AI Can Identify Focal Dystonia Instantly

By MedImaging International staff writers
Posted on 13 Oct 2020
Image: Comparison of the MRI scans processed by DystoniaNet (Photo courtesy of MEEI)
Image: Comparison of the MRI scans processed by DystoniaNet (Photo courtesy of MEEI)
The conjunction of magnetic resonance imaging (MRI) and artificial intelligence (AI) can identify patients with dystonia in under a second, according to a new study.

The new platform, called DystoniaNet, developed at the Massachusetts Eye and Ear Infirmary (MEEI; Boston, USA), can identify a microstructural neural network biomarker that allows objective and accurate diagnosis of isolated dystonia, based on the disorder pathophysiology and MRI structural brain images. The algorithm was developed using the MRI’s of 612 subjects, including 392 with three forms of isolated focal dystonia (laryngeal dystonia, cervical dystonia, and blepharospasm), and those of 220 healthy controls.

DystoniaNet successfully identified clusters in the corpus callosum, the anterior and posterior thalamic radiations, the inferior fronto-occipital fasciculus, and inferior temporal and superior orbital gyri as the biomarker components, regions that are known to contribute to abnormal interhemispheric information transfer, heteromodal sensorimotor processing, and executive control of motor commands. In all, the DystoniaNet AI biomarker showed an accuracy of 98.8% in diagnosing dystonia, with a referral of 3.5% of cases due to diagnostic uncertainty.

DystoniaNet also outperformed shallow machine-learning algorithms, showing nearly a 20% increase in benchmark diagnostic performance. Importantly, the microstructural neural network biomarker and its DystoniaNet platform showed substantial improvement over the current 34% agreement on dystonia diagnosis between clinicians. In addition, the diagnostic decision by DystoniaNet was computed in just 0.36 seconds. The study was published on October 1, 2020, in PNAS.

“We basically leveraged the advances made in deep learning and designed an architecture that was able to look at raw structural MRI and find a biomarker for dystonia that could help with the diagnosis of this disorder,” said study author Davide Valeriani, PhD. “We specifically took an approach that could be easily clinically translated, which is why we used raw structural MRI. Given the platform's performance and the average length of time to diagnosis, it has potential to beneficial impact the movement disorder field.”

Dystonia is a neurological disorder of heterogeneous pathophysiology, which causes involuntary muscle contractions leading to abnormal movements and postures. Its diagnosis is remarkably challenging due to the absence of a biomarker or gold standard diagnostic test. This leads to a low agreement between clinicians, with up to 50% of cases being misdiagnosed and diagnostic delays extending up to 10 years.

Related Links:
Massachusetts Eye and Ear Infirmary

Radiology Software
DxWorks
Ultra-Flat DR Detector
meX+1717SCC
Ultrasound Imaging System
P12 Elite
3T MRI Scanner
MAGNETOM Cima.X

Channels

Ultrasound

view channel
Image: The new implantable device for chronic pain management is small and flexible (Photo courtesy of The Zhou Lab at USC)

Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery

Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.